In Ma et al.’s work, FOS was observed to boost SOD and GSH-Px activity in the kidneys, lower MDA levels, and mitigate adenine-induced kidney damage via antioxidative mechanisms [50]. The gene discussed is FOS; the disease is Nephropathy.